Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Preclinical research evidence Animal Experiments Obese mouse model: After subcutaneous injection of AOD 9604 (250 g/kg) daily for 8 weeks, the body weight of obese mice decreased by 12%, the subcutaneous fat mass decreased by 25%, and the weight of epididymal adipose tissue decreased significantly
Frontier Peptide Labs Epithalon is intended exclusively for laboratory research and development purposes
Anti-inflammatory signaling: TB-500 reduces inflammatory cytokine activity in the affected tissue environment
Hydroxycobalamin is another highly effective form that converts into the bodys active coenzyme forms
Published animal and in vitro research points to several distinct pathways, none of which have been confirmed in a human pharmacodynamic trial
